Neurostimulation Methods in the Treatment of Depression: A Comparison of rTMS, tDCS, and Venlafaxine Using a Pooled Analysis of Two Studies

Martin Hejzlar,1,2 Tomas Novak,1,2 Martin Bares1,2 1NIMH Clinical Center, National Institute of Mental Health Czech Republic, Klecany, Czech Republic; 2Department of Psychiatry and Medical Psychology, Third Medical Faculty, Charles University, Prague, Czech RepublicCorrespondence: Martin HejzlarNati...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Hejzlar M, Novak T, Bares M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	repetitive transcranial magnetic stimulation (rtms) transcranial direct-current stimulation (tdcs) venlafaxine major depressive disorder (mdd) treatment efficacy Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/37ef903c443f4b8180b29e5820a8d4aa
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:37ef903c443f4b8180b29e5820a8d4aa
record_format	dspace
spelling	oai:doaj.org-article:37ef903c443f4b8180b29e5820a8d4aa2021-12-02T16:54:00ZNeurostimulation Methods in the Treatment of Depression: A Comparison of rTMS, tDCS, and Venlafaxine Using a Pooled Analysis of Two Studies1178-2021https://doaj.org/article/37ef903c443f4b8180b29e5820a8d4aa2021-05-01T00:00:00Zhttps://www.dovepress.com/neurostimulation-methods-in-the-treatment-of-depression-a-comparison-o-peer-reviewed-fulltext-article-NDThttps://doaj.org/toc/1178-2021Martin Hejzlar,1,2 Tomas Novak,1,2 Martin Bares1,2 1NIMH Clinical Center, National Institute of Mental Health Czech Republic, Klecany, Czech Republic; 2Department of Psychiatry and Medical Psychology, Third Medical Faculty, Charles University, Prague, Czech RepublicCorrespondence: Martin HejzlarNational Institute of Mental Health Czech Republic, Topolova 748, Klecany, 250 67, Czech RepublicTel +420 283 088 314Email Martin.Hejzlar@nudz.czBackground: There are no head-to-head studies comparing the antidepressant effect of transcranial direct current stimulation (tDCS) with repetitive transcranial magnetic stimulation (rTMS). This pooled analysis compared indirectly the antidepressant efficacy and acceptability of rTMS, tDCS, and the antidepressant venlafaxine (VNF) extended-release.Methods: The analysis (n=117, both patients with treatment-resistant depression (TRD) and non-TRD were included) examined pooled data from two 4-week, single-centered, two-armed, double-blind, randomized studies (EUDRACT n. 2005-000826-22 and EUDRACT n. 2015-001639-19). The antidepressant efficacy of right-sided low-frequency rTMS (n=29) vs VNF (n=31) and left-sided anodal tDCS (n=29) vs VNF (n=28) was evaluated. The primary outcome was a change in the Montgomery–Åsberg Depression Rating Scale (MADRS) score from baseline to the treatment endpoint at week 4. The response was defined as a ≥ 50% reduction in the MADRS score and remission as the MADRS score ≤ 10 points, both were calculated for the primary treatment endpoint at week 4.Results: Mean change in total MADRS scores from baseline to week 4 was 7.0 (95% CI, 4.8– 9.1) points in the rTMS group, 7.6 (95% CI, 5.5– 9.8) in the tDCS group, and 8.9 (95% CI, 7.4– 10.4) among patients in the VNF group, a non-significant difference (F(2111)=0.62, p=0.54). Similarly, neither the response rates nor remission rates for rTMS (response 31%; remission 17%), tDCS (24%, 17%), or VNF (41%; 27%) significantly differed among treatment groups (χ2=2.59, p=0.28; χ2=1.66, p=0.44). Twenty patients (17%) dropped out of the studies in a similar proportion across groups (rTMS 3/29, tDCS 6/29, VNF 11/59, χ2=1.41, p=0.52).Conclusion: Our current analysis found a comparable efficacy and acceptability in all three treatment modalities (rTMS, tDCS, and VNF) and clinical relevance for the acute treatment of major depressive disorder.Keywords: repetitive transcranial magnetic stimulation, rTMS, transcranial direct-current stimulation, tDCS, venlafaxine, major depressive disorder, MDD, treatment, efficacyHejzlar MNovak TBares MDove Medical Pressarticlerepetitive transcranial magnetic stimulation (rtms)transcranial direct-current stimulation (tdcs)venlafaxinemajor depressive disorder (mdd)treatmentefficacyNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 17, Pp 1713-1722 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	repetitive transcranial magnetic stimulation (rtms) transcranial direct-current stimulation (tdcs) venlafaxine major depressive disorder (mdd) treatment efficacy Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	repetitive transcranial magnetic stimulation (rtms) transcranial direct-current stimulation (tdcs) venlafaxine major depressive disorder (mdd) treatment efficacy Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Hejzlar M Novak T Bares M Neurostimulation Methods in the Treatment of Depression: A Comparison of rTMS, tDCS, and Venlafaxine Using a Pooled Analysis of Two Studies
description	Martin Hejzlar,1,2 Tomas Novak,1,2 Martin Bares1,2 1NIMH Clinical Center, National Institute of Mental Health Czech Republic, Klecany, Czech Republic; 2Department of Psychiatry and Medical Psychology, Third Medical Faculty, Charles University, Prague, Czech RepublicCorrespondence: Martin HejzlarNational Institute of Mental Health Czech Republic, Topolova 748, Klecany, 250 67, Czech RepublicTel +420 283 088 314Email Martin.Hejzlar@nudz.czBackground: There are no head-to-head studies comparing the antidepressant effect of transcranial direct current stimulation (tDCS) with repetitive transcranial magnetic stimulation (rTMS). This pooled analysis compared indirectly the antidepressant efficacy and acceptability of rTMS, tDCS, and the antidepressant venlafaxine (VNF) extended-release.Methods: The analysis (n=117, both patients with treatment-resistant depression (TRD) and non-TRD were included) examined pooled data from two 4-week, single-centered, two-armed, double-blind, randomized studies (EUDRACT n. 2005-000826-22 and EUDRACT n. 2015-001639-19). The antidepressant efficacy of right-sided low-frequency rTMS (n=29) vs VNF (n=31) and left-sided anodal tDCS (n=29) vs VNF (n=28) was evaluated. The primary outcome was a change in the Montgomery–Åsberg Depression Rating Scale (MADRS) score from baseline to the treatment endpoint at week 4. The response was defined as a ≥ 50% reduction in the MADRS score and remission as the MADRS score ≤ 10 points, both were calculated for the primary treatment endpoint at week 4.Results: Mean change in total MADRS scores from baseline to week 4 was 7.0 (95% CI, 4.8– 9.1) points in the rTMS group, 7.6 (95% CI, 5.5– 9.8) in the tDCS group, and 8.9 (95% CI, 7.4– 10.4) among patients in the VNF group, a non-significant difference (F(2111)=0.62, p=0.54). Similarly, neither the response rates nor remission rates for rTMS (response 31%; remission 17%), tDCS (24%, 17%), or VNF (41%; 27%) significantly differed among treatment groups (χ2=2.59, p=0.28; χ2=1.66, p=0.44). Twenty patients (17%) dropped out of the studies in a similar proportion across groups (rTMS 3/29, tDCS 6/29, VNF 11/59, χ2=1.41, p=0.52).Conclusion: Our current analysis found a comparable efficacy and acceptability in all three treatment modalities (rTMS, tDCS, and VNF) and clinical relevance for the acute treatment of major depressive disorder.Keywords: repetitive transcranial magnetic stimulation, rTMS, transcranial direct-current stimulation, tDCS, venlafaxine, major depressive disorder, MDD, treatment, efficacy
format	article
author	Hejzlar M Novak T Bares M
author_facet	Hejzlar M Novak T Bares M
author_sort	Hejzlar M
title	Neurostimulation Methods in the Treatment of Depression: A Comparison of rTMS, tDCS, and Venlafaxine Using a Pooled Analysis of Two Studies
title_short	Neurostimulation Methods in the Treatment of Depression: A Comparison of rTMS, tDCS, and Venlafaxine Using a Pooled Analysis of Two Studies
title_full	Neurostimulation Methods in the Treatment of Depression: A Comparison of rTMS, tDCS, and Venlafaxine Using a Pooled Analysis of Two Studies
title_fullStr	Neurostimulation Methods in the Treatment of Depression: A Comparison of rTMS, tDCS, and Venlafaxine Using a Pooled Analysis of Two Studies
title_full_unstemmed	Neurostimulation Methods in the Treatment of Depression: A Comparison of rTMS, tDCS, and Venlafaxine Using a Pooled Analysis of Two Studies
title_sort	neurostimulation methods in the treatment of depression: a comparison of rtms, tdcs, and venlafaxine using a pooled analysis of two studies
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/37ef903c443f4b8180b29e5820a8d4aa
work_keys_str_mv	AT hejzlarm neurostimulationmethodsinthetreatmentofdepressionacomparisonofrtmstdcsandvenlafaxineusingapooledanalysisoftwostudies AT novakt neurostimulationmethodsinthetreatmentofdepressionacomparisonofrtmstdcsandvenlafaxineusingapooledanalysisoftwostudies AT baresm neurostimulationmethodsinthetreatmentofdepressionacomparisonofrtmstdcsandvenlafaxineusingapooledanalysisoftwostudies
_version_	1718382850407923712

Neurostimulation Methods in the Treatment of Depression: A Comparison of rTMS, tDCS, and Venlafaxine Using a Pooled Analysis of Two Studies

Ejemplares similares